Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients

NCT02822950 is registered in ClinicalTrials.gov with Michigan State University as lead sponsor.

NCT NCT02822950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients
Lead sponsor
Michigan State University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2017
Completion date
December 31, 2017
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics of avycaz in icu patients